DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Maxalt (Rizatriptan Benzoate) - Summary

 
 



MAXALT SUMMARY

What is MAXALT and what is it used for?

MAXALT contains rizatriptan benzoate, a selective 5-hydroxytryptamine1B/1D(5-HT1B/1D) receptor agonist.

MAXALT is indicated for the acute treatment of migraine attacks with or without aura in adults.

MAXALT is not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine (see CONTRAINDICATIONS). Safety and effectiveness of MAXALT have not been established for cluster headache, which is present in an older, predominantly male population.


See all Maxalt indications & dosage >>

NEWS HIGHLIGHTS

Media Articles Related to Maxalt (Rizatriptan)

Migraines: unique data collected from sufferers sharing pain on Twitter
Source: Headache / Migraine News From Medical News Today [2014.04.06]
In under 140 characters, migraine sufferers have described their pain on Twitter. Now, researchers have analyzed these migraine-related tweets, revealing social data on impacts.

Could Reducing Stress Help Bring On a Migraine?
Source: MedicineNet Stress Specialty [2014.04.02]
Title: Could Reducing Stress Help Bring On a Migraine?
Category: Health News
Created: 4/1/2014 5:36:00 PM
Last Editorial Review: 4/2/2014 12:00:00 AM

FDA approves Topamax for migraine prevention in adolescents
Source: Headache / Migraine News From Medical News Today [2014.04.01]
The U.S. Food and Drug Administration has approved Topamax (topiramate) for prevention (prophylaxis) of migraine headaches in adolescents ages 12 to 17.

Topamax Approval for Migraines Expanded to Younger Users
Source: MedicineNet topiramate Specialty [2014.04.01]
Title: Topamax Approval for Migraines Expanded to Younger Users
Category: Health News
Created: 3/31/2014 12:36:00 PM
Last Editorial Review: 4/1/2014 12:00:00 AM

New research explores the impact of stress reduction on migraine attacks
Source: Headache / Migraine News From Medical News Today [2014.03.29]
Migraine sufferers who experienced reduced stress from one day to the next are at significantly increased risk of migraine onset on the subsequent day, according to a new study conducted by...

more news >>

Published Studies Related to Maxalt (Rizatriptan)

Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders. [2011.05]
OBJECTIVE: The study was carried out to assess the efficacy and tolerability of rizatriptan orally disintegrating tablet (ODT) for treating acute migraine in patients who are non-responders to sumatriptan. BACKGROUND: Many migraineurs report dissatisfaction with sumatriptan efficacy. It is unclear whether sumatriptan 100 mg non-responders will respond to other triptans... CONCLUSION: Rizatriptan 10-mg ODT was superior to placebo at providing two-hour pain relief and two-hour pain freedom in the treatment of acute migraine in those who do not respond to sumatriptan 100 mg. Rizatriptan was generally well tolerated in this population.

A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine. [2011.04]
The objective of this study was to assess patient satisfaction with acute treatment of migraine with frovatriptan or rizatriptan by preference questionnaire. 148 subjects with a history of migraine with or without aura (IHS 2004 criteria), with at least one migraine attack per month in the preceding 6 months, were enrolled and randomized to frovatriptan 2.5 mg or rizatriptan 10 mg treating 1-3 attacks...

Rizatriptan reduces vestibular-induced motion sickness in migraineurs. [2011.02]
A previous pilot study suggested that rizatriptan reduces motion sickness induced by complex vestibular stimulation. In this double-blind, randomized, placebo-controlled study we measured motion sickness in response to a complex vestibular stimulus following pretreatment with either rizatriptan or a placebo...

Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan. [2011]
The objectives of this study are to assess the efficacy and safety of frovatriptan, and rizatriptan in the subgroup of women with menstrually related migraine of a multicenter, randomized, double blind, cross-over study. Each patient received frovatriptan 2.5 mg or rizatriptan 10 mg in a randomized sequence: after treating 3 episodes of migraine in not more than 3 months with the first treatment, the patient had to switch to the other treatment...

A pilot study of rizatriptan and visually-induced motion sickness in migraineurs. [2009.08.06]
CONCLUSIONS: These pilot data suggest that rizatriptan does not consistently reduce visually-induced motion sickness in migraineurs. Rizatriptan may diminish motion sickness potentiation by cranial pain.

more studies >>

Clinical Trials Related to Maxalt (Rizatriptan)

Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache [Active, not recruiting]
The purpose of this study is to evaluate the effect of rizatriptan, alone or combined with caffeine for treating acute attacks of migraine.

Each subject will have 3 months to treat 3 acute migraine headache attacks. Each subject will be dispensed one box containing 3 packets of study medication labeled for Headache #1, Headache #2, or Headache #3. Each packet wil contain either Maxalt 10mg MLT or a Maxalt placebo (sugar pill), and a capsule containing either caffeine 75mg or a capsule containing placebo (sugar).

One headache will be treated with a combination of Maxalt 10mg MLT and caffeine.

Another headache will be treated with a combination of Maxalt 10mg MLT and a capsule containing placebo.

A third headache will be treated with just placebo.

Neither the subject, the study coordinator, or your study doctor will know in which order you will receive the three different treatments. This information is available in case of emergency.

Two Rizatriptan Prescribing Portions for Treatment of Migraine [Completed]

Study of Rizatriptan in the Treatment of Acute Attacks of Post-traumatic Headache in U.S. Military Troops [Recruiting]

Study to Test a Marketed Drug (MK0462) in the Early Treatment of Acute Migraine [Active, not recruiting]

Drug Study in Pediatric Subjects With Migraines [Active, not recruiting]
A study to assess the safety, tolerability, and single dose pharmacokinetics of a marketed drug in pediatric subjects with migraines

more trials >>

Reports of Suspected Maxalt (Rizatriptan) Side Effects

Drug Ineffective (14)Migraine (10)Chest Pain (8)Tremor (8)Chest Discomfort (7)Vomiting (7)Depression (6)Muscle Twitching (5)Disability (5)Blood Creatine Phosphokinase Increased (4)more >>


PATIENT REVIEWS / RATINGS / COMMENTS

Based on a total of 10 ratings/reviews, Maxalt has an overall score of 9.40. The effectiveness score is 9.60 and the side effect score is 8.20. The scores are on ten point scale: 10 - best, 1 - worst. Below are selected reviews: the highest, the median and the lowest rated.
 

Maxalt review by 47 year old female patient

  Rating
Overall rating:  
Effectiveness:   Highly Effective
Side effects:   Mild Side Effects
  
Treatment Info
Condition / reason:   Migraines
Dosage & duration:   10 mg taken as needed for the period of Ongoing
Other conditions:   None
Other drugs taken:   Birth control
  
Reported Results
Benefits:   Normally takes away a headache with an hour when absolutely nothing else will work.
Side effects:   Sometimes will give a feeling of tightness in the chest and some drowsiness. If taken too often can cause rebound headaches.
Comments:   You take one Maxalt at the onset of a migraine. It can be repeated after two hours.

 

Maxalt review by 38 year old female patient

  Rating
Overall rating:  
Effectiveness:   Considerably Effective
Side effects:   Mild Side Effects
  
Treatment Info
Condition / reason:   Migraine
Dosage & duration:   10mg taken 2-6x/year for the period of 1 year
Other conditions:   none
Other drugs taken:   none
  
Reported Results
Benefits:   Decreased headache pain from 10/10 to 0/10 within a few hours. Took at least 30 minutes to feel pain start to decrease, then causes fatigue. I like the fact that it disintegrates sublingually, because vomiting is often associated with my headaches and I am never sure how much medication is retained afterward if I have taken a tablet.
Side effects:   It always puts me to sleep for an hour or two. After waking, I sometimes feel a little shakey, but the pain is gone. I wouldn't take this med if I were out of the house due to the grogginess.
Comments:   Treatment for migraine when otc's, or prescription level ibuprophen (800 mg) are not effective. Used for moderate migraine if it lasts a few days, or when pain reaches 8 to 10/10.

 

Maxalt review by 38 year old female patient

  Rating
Overall rating:  
Effectiveness:   Considerably Effective
Side effects:   Mild Side Effects
  
Treatment Info
Condition / reason:   Migraine
Dosage & duration:   10mg taken monthly for the period of ongoing
Other conditions:   none
Other drugs taken:   none
  
Reported Results
Benefits:   The drug melts on the tongue so there is no need for water and is great when you need to take a tablet in the car etc. It is effective as soon as the effects of a migraine appear and I would reccommend it to anyone who suffers.
Side effects:   I sometimes feel nausea (May also be due to migraine itself). I get sonstipated
Comments:   One tablet is taken whne required and a second one can be taken after two hours no more than 2 to be taken in 24 hours

See all Maxalt reviews / ratings >>

Page last updated: 2014-04-06

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012